Compounding Pharmacies Market by Product, Application, Therapeutic Area and Region - Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2032

4%
CAGR (2025-2032)
10.39 USD Bn.
Market Size
312
Report Pages
142
Market Tables

Overview

The Compounding Pharmacies Market size was valued at USD 10.39  Billion in 2024 and the total Compounding Pharmacies revenue is expected to grow at a CAGR of 4% from 2025 to 2032, reaching nearly USD 14.22 Billion.

Favourable demographic inclinations towards improved life expectancy coupled with rising geriatric population will render substantial positive impact on Global Compounding Pharmacies Market growth. Patient of old age normally needs dosage forms and drug excipients that are unalike from commercially available products in market. In such circumstances, compounded medications tailor-made to individual needs allow superior handling of disease conditions. As a result, growing number of geriatric population will boost the market for compounded medications.

Compounding Pharmacies Market 2025-2032To know about the Research Methodology:-Request Free Sample Report

Dearth of availability of skilled workforce coupled with high cost of sophisticated equipment required for compounding medicines might hamper the market growth by 2024. Continuously, changing regulations will further hinder the industry growth affecting the production of compounded drugs on large scale. Lack of timely availability of customary drugs will lead the demand for compounded medications. Shortage of drugs might have severe repercussion such as death of patients. For instance, Europe and North America region have witnessed substantial drug shortage over past few years.

Oral product segment from Global Market accounted for highest market share in 2024. The high market value is owed to the growing demand for compounded oral medicine, particularly in the domain of pain management. Additionally, the oral liquid dosage forms are favoured due to associated ease of administration and convenience. Geriatric people time and again desire liquid oral dosage form in auxiliary to commercially available dosage forms.

Adult application segment will show a robust growth over the upcoming years. Increasing prevalence of cardiovascular, respiratory oncology, viral, and bacterial diseases in adult population will mainly boost the segment growth. Women over the age of 40years suffering from hormonal changes in their body require compounded hormonal medications. This will additionally support the segment growth over the forecast timeframe.

Compounding Pharmacies Market Scope: Inquire before buying

Global Compounding Pharmacies Market
Report Coverage Details
Base Year: 2024 Forecast Period: 2025-2032
Historical Data: 2019 to 2024 Market Size in 2024: USD 10.39 Bn.
Forecast Period 2025 to 2032 CAGR: 4 % Market Size in 2032: USD 14.22 Bn.
Segments Covered: by Product Oral
Solid preparations
         Tablets
         Capsules
         Granules
         Powder
         Others
Liquid preparations
        Solutions
        Suspension
         Emulsion
         Syrup
         Others
Topical
         Ointments
         Creams
         Gels
         Pastes
         Others
Rectal
         Suppositories
         Edema
          Others
Parenteral
Inhaler
Ophthalmic
          Eye drops
          Ear drops
          Nasal drops
          Others
by Application Pediatrics
Adult
Geriatric
Veterinary Therapeutic Area
Hormone Replacement
Pain Management
by Therapeutic Area Dermatology
Pain management
Specialty drugs
Nutritional supplements
Hormone replacement
Others

Compounding Pharmacies Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Compounding Pharmacies Market, Key Players

1. B. BraunAthenex Pharma Solutions
2. Fresenius Kabi
3. Clinigen Group PLC
4. Dougherty's Pharmacy, Inc.
5. Fagron
6. Lorraine’s Pharmacy
7. Institutional Pharmacy Solutions
8. McGuff Company Inc.
9. Nephron Pharmaceuticals Corporation
10. Rx3 Compounding Pharmacy
11. Wedgewood Village Pharmacy, Inc.
12. Pencol Compounding Pharmacy
13. Triangle Compounding Pharmacies
14. Wedgewood Village Pharmacy, Inc.
15. PharMEDium Services, LLC
16. Cantrell Drug Company
17. Elixir Compounding Pharmacy
18. Avella specialty pharmacy
19. US Compounding Inc
20. Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd

Frequently Asked Questions:

1] What segments are covered in the Compounding Pharmacies Market report?
Ans. The segments covered in the Market report are based on Product and application.

2] Which region is expected to hold the highest share in the Compounding Pharmacies Market?
Ans. The Asia Pacific region is expected to hold the highest share in the Compounding Pharmacies Market.

3] What is the market size of the Compounding Pharmacies Market by 2032?
Ans. The market size of the Compounding Pharmacies Market by 2032 is USD 14.22 Bn.

4] What is the forecast period for the Compounding Pharmacies Market?
Ans. The forecast period for the Compounding Pharmacies Market is 2025-2032.

5] What was the Global Compounding Pharmacies Market size in 2024?
Ans: The Global Compounding Pharmacies Market size was USD 10.39 Billion in 2024.

Table of Contents

1. Global Compounding Pharmacies Market: Research Methodology 2. Global Compounding Pharmacies Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Compounding Pharmacies Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Compounding Pharmacies Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Compounding Pharmacies Market Segmentation 4.1 Global Compounding Pharmacies Market, by Product (2024-2032) • Oral o Solid preparations  Tablets  Capsules  Granules  Powder  Others o Liquid preparations  Solutions  Suspension  Emulsion  Syrup  Others • Topical o Ointments o Creams o Gels o Pastes o Others • Rectal o Suppositories o Edema o Others • Parenteral • Inhaler • Ophthalmic o Eye drops o Ear drops o Nasal drops o Others 4.2 Global Compounding Pharmacies Market, by Application (2024-2032) • Pediatrics • Adult • Geriatric • Veterinary Therapeutic Area • Hormone Replacement • Pain Management 4.3 Global Compounding Pharmacies Market, by Therapeutic Area (2024-2032) • Dermatology • Pain management • Specialty drugs • Nutritional supplements • Hormone replacement • Others 5. North America Compounding Pharmacies Market(2024-2032) 5.1 North America Compounding Pharmacies Market, by Product (2024-2032) • Oral o Solid preparations  Tablets  Capsules  Granules  Powder  Others o Liquid preparations  Solutions  Suspension  Emulsion  Syrup  Others • Topical o Ointments o Creams o Gels o Pastes o Others • Rectal o Suppositories o Edema o Others • Parenteral • Inhaler • Ophthalmic o Eye drops o Ear drops o Nasal drops o Others 5.2 North America Compounding Pharmacies Market, by Application (2024-2032) • Pediatrics • Adult • Geriatric • Veterinary Therapeutic Area • Hormone Replacement • Pain Management 5.3 North America Compounding Pharmacies Market, by Therapeutic Area (2024-2032) • Dermatology • Pain management • Specialty drugs • Nutritional supplements • Hormone replacement • Others 5.4 North America Compounding Pharmacies Market, by Country (2024-2032) • United States • Canada • Mexico 6. Europe Compounding Pharmacies Market (2024-2032) 6.1. European Compounding Pharmacies Market, by Product (2024-2032) 6.2. European Compounding Pharmacies Market, by Application (2024-2032) 6.3. European Compounding Pharmacies Market, by Therapeutic Area (2024-2032) 6.4. European Compounding Pharmacies Market, by Country (2024-2032) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Compounding Pharmacies Market (2024-2032) 7.1. Asia Pacific Compounding Pharmacies Market, by Product (2024-2032) 7.2. Asia Pacific Compounding Pharmacies Market, by Application (2024-2032) 7.3. Asia Pacific Compounding Pharmacies Market, by Therapeutic Area (2024-2032) 7.4. Asia Pacific Compounding Pharmacies Market, by Country (2024-2032) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Compounding Pharmacies Market (2024-2032) 8.1 Middle East and Africa Compounding Pharmacies Market, by Product (2024-2032) 8.2. Middle East and Africa Compounding Pharmacies Market, by Application (2024-2032) 8.3. Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area (2024-2032) 8.4. Middle East and Africa Compounding Pharmacies Market, by Country (2024-2032) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Compounding Pharmacies Market (2024-2032) 9.1. South America Compounding Pharmacies Market, by Product (2024-2032) 9.2. South America Compounding Pharmacies Market, by Application (2024-2032) 9.3. South America Compounding Pharmacies Market, by Therapeutic Area (2024-2032) 9.4 South America Compounding Pharmacies Market, by Country (2024-2032) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 B. BraunAthenex Pharma Solutions 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Fresenius Kabi 10.3 Clinigen Group PLC 10.4 Dougherty's Pharmacy, Inc. 10.5 Fagron 10.6 Lorraine’s Pharmacy 10.7 Institutional Pharmacy Solutions 10.8 McGuff Company Inc. 10.9 Nephron Pharmaceuticals Corporation 10.10 Rx3 Compounding Pharmacy 10.11 Wedgewood Village Pharmacy, Inc. 10.12 Pencol Compounding Pharmacy 10.13 Triangle Compounding Pharmacies 10.14 Wedgewood Village Pharmacy, Inc. 10.15 PharMEDium Services, LLC 10.16 Cantrell Drug Company 10.17 Elixir Compounding Pharmacy 10.18 Avella specialty pharmacy 10.19 US Compounding Inc

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements